Jujuboside B Reverse CUMS-Promoted Tumor Progression via Blocking PI3K/Akt and MAPK/ERK and Dephosphorylating CREB Signaling

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td class="align_left">Gene name</td><td class="align_center">Forward</td><td class="align_center">Reverse</td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td class="align_left">GAPDH</td><td class="align_center">GACATGCCGCCTGGAGAAAC</td><td class="align_center">AGCCCAGGATGCCCTTTAGT</td></tr><tr><td class="align_left">Bax</td><td class="align_center">TGCTGCCTTTTCTGTTCCTT</td><td class="align_center">AAGGTGCTGGGTAGGGAAGT</td></tr><tr><td class="align_left">Bcl-2</td><td class="align_center">GTCCACGAACCCGTAAGGT</td><td class="align_center">CATCTTTTCCCGATAGGTCCA</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>Primer sequences of mRNA analysis.</div>

Journal of Immunology Research

tab2

Table 2

Table 2: Jujuboside B Reverse CUMS-Promoted Tumor Progression via Blocking PI3K/Akt and MAPK/ERK and Dephosphorylating CREB Signaling 